Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Ichiro Fujii

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 2, 2009
[Immunological evaluation for CML and its possibility for an immunotherapy]Shin-ichiro Fujii
Trends in Immunology|March 29, 2008
Exploiting dendritic cells and natural killer T cells in immunotherapy against malignanciesShin-ichiro Fujii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Immune cell contexture in the tumor microenvironment]Shin-Ichiro Fujii
International Journal of Hematology|February 19, 2005
Application of natural killer T-cells to posttransplantation immunotherapyShin-ichiro Fujii
Frontiers in Immunology|August 22, 2017
Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic CellsShin-Ichiro Fujii, Kanako Shimizu
Trends in Immunology|November 3, 2019
Immune Networks and Therapeutic Targeting of iNKT Cells in CancerShin-Ichiro Fujii, Kanako Shimizu
Oncoimmunology|June 5, 2013
Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune responseShin-Ichiro Fujii, Kanako Shimizu
European Journal of Immunology|January 31, 2009
DC therapy induces long-term NK reactivity to tumors via host DCKanako Shimizu, Shin-ichiro Fujii
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunityKanako Shimizu, Shin-ichiro Fujii
Critical Reviews in Oncogenesis|February 29, 2024
NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer TreatmentShin-Ichiro Fujii, Kanako Shimizu
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 2, 2009
[Immunological evaluation for CML and its possibility for an immunotherapy]Shin-ichiro Fujii
Trends in Immunology|March 29, 2008
Exploiting dendritic cells and natural killer T cells in immunotherapy against malignanciesShin-ichiro Fujii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Immune cell contexture in the tumor microenvironment]Shin-Ichiro Fujii
International Journal of Hematology|February 19, 2005
Application of natural killer T-cells to posttransplantation immunotherapyShin-ichiro Fujii
Frontiers in Immunology|August 22, 2017
Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic CellsShin-Ichiro Fujii, Kanako Shimizu
Trends in Immunology|November 3, 2019
Immune Networks and Therapeutic Targeting of iNKT Cells in CancerShin-Ichiro Fujii, Kanako Shimizu
Oncoimmunology|June 5, 2013
Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune responseShin-Ichiro Fujii, Kanako Shimizu
European Journal of Immunology|January 31, 2009
DC therapy induces long-term NK reactivity to tumors via host DCKanako Shimizu, Shin-ichiro Fujii
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunityKanako Shimizu, Shin-ichiro Fujii
Critical Reviews in Oncogenesis|February 29, 2024
NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer TreatmentShin-Ichiro Fujii, Kanako Shimizu
Pageof 12